Angiogenesis Inflammation a b s t r a c t MicroRNAs are a class of small RNAs that regulate the expression of target mRNAs by inhibiting translation or destabilizing target mRNAs. miR-126 is a microRNA that is highly enriched in endothelial cells. miR-126 has been found to promote angiogenesis and inhibit vascular inflammation in endothelial cells by repressing three target genes Sprouty-related EVH1 domain-containing protein 1 (SPRED1), phosphoinositol-3 kinase regulatory subunit 2 (PIK3R2), and vascular cell adhesion molecule 1 (VCAM1). Our previous study showed that the expression of miR-126 was downregulated after spinal cord injury (SCI). Therefore, we wanted to examine whether upregulation of miR-126 could promote angiogenesis, inhibit inflammation, and exert a positive effect on recovery after contusion SCI. In this study, we found that increased levels of miR-126 promoted angiogenesis, and inhibited leukocyte extravasation into the injured spinal cord, which was concurrent with downregulation of mRNA and protein expression of three validated miR-126 target genes, SPRED1, PIK3R2, and VCAM1. Moreover, a dose-dependent effect of miR-126 was observed in rescuing tissue damage and improving the functional deficit after SCI. Thus, the present study indicated that miR-126 played an important role in angiogenesis and inflammation after SCI.
Introduction
Contusive spinal cord injury (SCI) is a devastating neurological injury that causes progressive tissue loss, secondary to vascular dysfunction and inflammation at the injury epicenter (Bramlett and Dietrich, 2007; Fleming et al., 2006; Norenberg et al., 2004) . Endothelial cells and blood vessels at the epicenter of the injured spinal cord show degenerative changes minutes after a primary injury. Significant decreases in microvascular endothelial cells are observed subsequently because of necrotic or apoptotic cell death (Casella et al., 2006; Dohrmann et al., 1971) . and produce oxidative and proteolytic enzymes such as myeloperoxidase (MPO) and NADPH, which provoke an inflammatory reaction (Bao et al., 2004; Brandes and Kreuzer, 2005; Taoka et al., 1997; Vaziri et al., 2004) . Two to three days later, most blood vessels are destroyed and are lost in the lesion epicenter (Benton et al., 2008; Loy et al., 2002) . While the surviving blood vessels become leaky (Whetstone et al., 2003) , mediating leukocyte infiltration and activating macrophages that are derived from blood-borne monocytes and resident microglia (Donnelly and Popovich, 2008 ). An abundance of oxidative and proteolytic enzymes is released and causes further tissue damage. The injured spinal cord became swollen and edematous, exacerbating the ischemia (Casella et al., 2006; Loy et al., 2002) , contributing to progressive degeneration and subsequent functional deficits (Hall and Springer, 2004; Norenberg et al., 2004; Tator and Fehlings, 1991; Tator and Koyanagi, 1997) . Three to seven days after SCI, an angiogenic response is seen within the epicenter gray matter, which results in minimization of the size of the lesion and maintenance of viability; however, this response might be too insignificant (Benton et al., 2008; Loy et al., 2002; Norenberg et al., 2004) .
In the past few years, studies that involved promotion of angiogenesis or attenuated the early inflammatory response demonstrated improved neurobehavioral recovery after SCI (Bethea, 2000; Gris et al., 2004; Han et al., 2010) . However, previous attempts to develop therapies were confounded by complex mechanisms in clinical settings; nevertheless, a satisfactory therapy has been discussed here.
MicroRNAs (miRs) constitute a class of small RNAs (approximately 20-25 nt) that regulate the expression of target mRNAs by inhibiting translation or destabilizing target mRNA. They greatly affect the regulation of signaling pathways that moderate common and specific functions across different cellular phenotypes and environments (Wu and Belasco, 2008; Zhao and Srivastava, 2007) . miR-126 is a microRNA that is highly enriched in endothelial cells (Harris et al., 2008) . Previous studies found that miR-126 plays an important role in vascular integrity and can promote angiogenesis during embryonic development and b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 -2 0 2 after injury (Fish et al., 2008; van Solingen et al., 2009; Wang et al., 2008) . miR-126 was also found to inhibit vascular inflammation by targeting an intercellular adhesion molecule that mediated leukocyte infiltration (Harris et al., 2008) . However, the specific roles of miR-126 in SCI have not yet been investigated. Our previous study found that the expression of miR-126 decreased after SCI (Hu et al., 2013) . Therefore, in this study, we wanted to examine whether upregulation of the level of miR-126 could promote angiogenesis, inhibit inflammation, and exert a positive effect on recovery after contusion SCI. A previous study found that the angiogenic response within the epicenter gray matter diminished and disappeared concurrently with cystic cavity formation; therefore, therapies targeting angiogenic processes should be directed at the subacute interval after SCI (Loy et al., 2002) . Therefore, we limited our intervention to 7 d to reduce the potential detrimental side effects of miR-126, which could occur at the same time.
Results

miR-126 reduced white matter loss following SCI
We determined effective doses of agomir-126 using white matter sparing at the epicenter as a measure because it correlates with locomotor function. Transverse sections in series of adjacent sections were used for measurements of white matter sparing and histological staining across all experiments. The injury epicenter was determined by the minimum area of myelin along the spinal cord axis. Compared to sham-operated (laminectomy only) rats with normal white matter (Fig. 1A ), rats treated with saline for 7 d (Fig. 1B) showed extensive loss of the ventral white matter after injury. In agomir-126-treated groups, much of the ventral and lateral white matter was spared ( Fig. 1C-E) . The white matter area at the epicenter was greatly spared with agomir-126 at 4, 20, or 100 nmol/mL than with saline at 7 d postinjury (Fig. 1K ). Intrathecal injections of miR-126 over 7 d at concentrations of 4, 20, or 100 nmol/mL showed that significantly better protection of white matter was obtained at 20 nmol/mL than at 4 nmol/mL and that the 100 nmol/mL dose did not further improve the outcome (Fig. 1K ). Histological changes were visualized by HE staining of adjacent sections ( Fig. 1F-J ).
miR-126 reduced locomotor deficits following SCI
miR-126 was tested for its effects on rescuing overground locomotion by using the BBB score (Fig. 2) . After SCI, all rats were paralyzed in both hind limbs. Spontaneous recovery of function after SCI was observed among groups. Significant difference in functional testing among groups was not observed until 7 d; at that time, following SCI, rats administered intrathecal injections of agomir-126 at a concentration of 4, 20, or 100 nmol/mL showed more elevated locomotor recovery than the saline-or negative control-treated groups. Rats treated with agomir-126 at a concentration of 20 or 100 nmol/mL showed significantly better protection of white matter than those treated with the 4 nmol/mL dose, and there was no statistical significance between the 20 and 100 nmol/mL groups. These results correlated well with the results of epicenter white matter sparing. A beneficial effect of miR-126 was also seen at 14 and 21 d and it was observed to last until 28 d. No statistically significant difference was observed between the saline-treated group and the negative control-treated group over 4 weeks of observation. Therefore, we used 20 nmol/mL agomir-126 for the subsequent experiments.
miR-126 improved vascularity at the injury site
We used FITC-LEA to determine the presence of perfused blood vessels at the epicenter, as LEA only binds to the endothelial cells of perfused blood vessels. Twenty-four hours after SCI, compared to the results for the shamoperated rats (Fig. 3A) , the number of LEA-labeled blood vessels around the epicenter greatly decreased in negative control and agomir-126-treated rats ( Fig. 3B and E) ; furthermore, agomir-126-treated rats had more blood vessels than negative control-treated rats, although this difference was not statistically significant (P ¼0.08). Seven days after injury, the blood vessels in rats treated with the negative control did not increase (P40.05) (Fig. 3C ). However, in agomir-126 treated rats, there was a significant increase in blood vessels at 7 d (Fig. 3G) compared to that at 24 h (Po0.05); more blood vessels were found in agomir-126 treated rats than negative control rats after 7-d treatment (Po0.01) (Fig. 3G ).
miR-126 reduced inflammation after SCI
Inflammation contributes to tissue damage after SCI. In this study, CD45 was used as a marker for extravasated leukocytes, and CD68 was used as a marker for activation of resident microglia and extravasated macrophages, which are major contributors to demyelination (Gris et al., 2004; Popovich et al., 1999; Shuman et al., 1997) . In this study, three consecutive sections at 1-mm distances spanning 3 mm rostral to 3 mm caudal from the epicenter were selected for staining. Samples from the sham-operated rats b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 -2 0 2 showed little or no immunostaining for CD45 and CD68 ( Fig. 4A and F). Twenty-four hours after SCI, there was no statistical significance between the negative control-and agomir-126-treated groups (data not shown). Seven days after injury, samples from rats treated with the negative control showed abundant CD45-positive cells throughout the epicenters of the spinal cords ( Fig. 4B and C) and in cells both rostral and caudal to it. This infiltration was markedly attenuated by agomir-126 ( Fig. 4D and E). Similar results were observed with CD68 immunostaining (Fig. 4G-K) . Peripheral leukocyte numbers were within the normal range in both the negative control and agomir-126 treated groups, at 7 d post-injury (Table 2) .
2.5.
The levels of three target genes were changed after miR-126 treatment In our study, the level of miR-126 decreased at 1, 3, and 7 d after SCI (Fig. 5A ). After 7 d treatment with agomir-126, the level of miR-126 in spinal cord increased (Fig. 6) . To explore the possible mechanism underlying the effect of miR-126 on SCI, we examined mRNA levels of miR-126 target genes and corresponding protein levels using qRT-PCR and Western blotting after agomir-126 treatment. The mRNA levels of two target genes, SPRED1 and PIK3R2, at 1, 3, and 7 d after SCI were lower than those of sham-operated rats (Fig. 5B and C) . Protein levels of these two targets correlated well with the mRNA changes (Fig. 7A) . The mRNA and protein levels of these two genes sharply decreased at 1, 3, and 7 d after agomir-126 treatment compared to those with negative control-treated rats.
The mRNA level of another target of miR-126, VCAM1, was elevated on 1, 3, and 7 d after SCI (Fig. 5D ). The mRNA level of VCAM1 at 3 and 7 d was lower after treatment with miR-126 agomir than in the negative control-treated groups (Fig. 5D ). However, we could not detect VCAM1 protein in either negative control or miR-126 agomir-treated groups. This lack of detection was not due to an ineffective antibody, since VCAM1 protein was detectible in positive control tissue (data not shown). b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 -2 0 2
We measured the phosphorylation status of ERK and AKT, two respective downstream targets of MAP and PI3 kinase pathways which can be activated by vascular endothelial growth factor stimulation. We found that the phosphorylation of ERK and AKT were lower than those of sham-operated rats at 7 d after SCI (Fig. 8) . Compared with the results for the negative control, treatment with agomir-126 increased phosphorylation of ERK (p-ERK) and AKT (p-AKT) at 7 d (Fig. 8) .
Discussion
In accordance with the results of our previous study (Hu et al., 2013) , we found that the expression of miR-126 was downregulated after SCI. Furthermore, in this study, we found that overexpression of miR-126 promoted angiogenesis, and inhibited leukocyte extravasation into the injured spinal cord, which was concurrent with downregulation of the mRNA and protein levels of three validated target genes of miR-126, SPRED1, PIK3R2, and VCAM1. Moreover, a dose-dependent effect of miR-126 was observed while rescuing tissue damage and improving the functional deficit after SCI. Thus, the present study indicated that miR-126 plays an important role in angiogenesis and inflammation after SCI. miR-126 is a microRNA that is highly enriched in endothelial cells (Harris et al., 2008) . miR-126, which is located in intron 7 of the EGF-like domain 7 (EGFl7) gene (Musiyenko et al., 2008) , is regulated by the transcription factors Ets-1 and Ets-2 in endothelial cells (Harris et al., 2010) . Previous studies found that miR-126 promoted stabilization and maturation of growing blood vessels by regulating angiopoietin-1 signaling (Sessa et al., 2012) and by repressing the p21-activated kinase 1 gene (Zou et al., 2011) . miR-126 has been found to promote angiogenesis during embryonic development and after injury by targeting coding mRNAs of SPRED1 and PIK3R2, that is, inhibitors of angiogenic and cell survival signals in response to vascular endothelial cell growth factor (VEGF). Knockdown of miR-126 during zebrafish and mice embryogenesis has been reported to result in delayed angiogenic sprouting, collapsed blood vessels, widespread hemorrhages, and partial embryonic lethality (Fish et al., 2008; Wang et al., 2008) . Moreover, mice treated with a high dose of antagomir-126 have been found to exhibit a markedly reduced angiogenic response after ischemia of the left hind limb (van Solingen et al., 2009 ).
In the current study, the number of blood vessels in the epicenters of injured spinal cords sharply decreased 24 h after SCI in rats, more blood vessels were observed at the injury site at 24 h post-SCI for rats treated with agomir-126 than for the negative control group; however, this difference was not statistically significant (Student's t-test, P¼ 0.08). At 7 d after SCI, no increase was observed in the number of blood vessels in the epicenters of injured spinal cords after 7-d treatment with the negative control, which is similar to the natural recovery process. Rats that were treated with agomir-126 for 7 d had a large increase in the number of blood vessels at the epicenter, numerous vessels reappeared in the dorsal column of injured spinal cord (Fig. 3F) , where the vessels were lost 1 day after injury (Fig. 3E) , suggesting that miR-126 could promote angiogenesis after SCI, as it does in vitro (Fish et al., 2008; Wang et al., 2008) . Collectively, these data suggest that miR-126 promotes therapeutic angiogenesis following SCI.
A previous study found that overexpression of miR-126 inhibited mRNA and protein expression of PI3KR2 and SPRED1 in endothelial cells (Fish et al., 2008) . SPRED1 is a member of the sprouty and sprouty-related protein family, which are negative regulators of growth factor signaling (Wakioka et al., 2001) . By binding and inactivating RAF1, an upstream kinase in the MAP kinase pathway, SPRED1 functioned as a membrane-associated suppressor of growth factor-induced ERK activation and blocked cell proliferation and migration in response to growth factor signaling, which are processes important for angiogenesis (Miyoshi et al., 2004; Nonami et al., 2004; Taniguchi et al., 2007) . SPRED1 could also regulate the cytoskeleton organization (Johne et al., 2008; Miyoshi et al., 2004) , a mechanism responsible for vasculature stabilization. PIK3R2 negatively regulated the activity of PI3 n Po0.05, nn Po0.01. b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 -2 0 2 kinase, a kinase important in the Akt pathway, which is related to an antiapoptotic effect (Ueki et al., 2003) . ERK and AKT are two respective downstream targets of MAP and PI3 kinase pathways which can be activated by vascular endothelial growth factor stimulation. In the current study, we found that the phosphorylation of ERK and AKT were decreased after SCI. Treatment with agomir-126 increased phosphorylation of ERK and AKT. We also found that the expression of SPRED1 and PIK3R2 were sharply decreased after agomir-126 treatment. Thus, these findings suggest that miR-126 could moderate the expression of these genes after SCI. Further studies should be done to get deep insight into the mechanisms of miR-126 and its target genes after SCI. We also observed an interesting phenomenon in which expression level of the miR-126 and its target genes SPRED1 and PIK3R2 all decreased after SCI, suggesting that the modulation of SPRED1 and PIK3R2 in SCI may involve multiple mechanisms in addition to miR-126. Therefore, more work should be performed to gain insights into the exact mechanism controlling SPRED1 and PIK3R2 expression. Therapies enhancing angiogenesis may have differing outcomes. Some researchers found that treatment with VEGF, a factor enhancing angiogenesis, improved the functional outcome and decreased secondary degeneration after SCI (Liu et al., 2010; Widenfalk et al., 2003) . Other researchers found that therapies promoting angiogenesis by activating Notch signaling had no effect on hind limb locomotor recovery after SCI (Fassbender et al., 2011) . Some studies have even reported that therapies enhancing angiogenesis have detrimental effects that exacerbate tissue damage and vascular permeability (Benton and Whittemore, 2003; Patel et al., 2009) . In this study, the current data contribute evidence to the idea that combining angiogenesis with vascular stabilization may have potential therapeutic applications following SCI, which correlates with other studies (Han et al., 2010; Herrera et al., 2010) .
In addition to promoting angiogenesis, miR-126 also has anti-inflammatory activity. VCAM1 is an adhesion molecule expressed by activated endothelial cells, which mediate leukocyte adherence to endothelial cells (Alon et al., 1995; Osborn et al., 1989) . By suppressing VCAM1 expression, miR-126 activity decreases leukocyte interactions with endothelial cells and attenuates vascular inflammation after injury (Asgeirsdottir et al., 2012; Harris et al., 2008 ). In the current study, rats treated with the negative control had abundant leukocytes and activated microglia/macrophages at the epicenter of the injured spinal cord on the 7th day. Reduced leukocyte infiltration and inflammation responses were seen after treatment with agomir-126 for 7 d, which suggests that miR-126 could inhibit leukocyte infiltration and reduce inflammation after SCI. The expression of VCAM1 decreased after agomir-126 treatment, which suggests that miR-126 can moderate VCAM1 expression in an SCI model.
Infiltrating leukocytes and inflammatory cells may act counter-productively after SCI. Apart from the detrimental effects of some leukocytes, such as the early arriving neutrophils and activated macrophages (Donnelly and Popovich, 2008; Weaver et al., 2005) , infiltrating leukocytes such as the M2-type macrophages showed beneficial effects that promoted cell survival and regeneration after SCI (Kigerl et al., 2009) . Thus, further work should be performed to better understand the effects of miR-126 on sub-classes of these cells.
Depending on the different cell types and the local environment, expression and signaling of miR-126 may vary greatly. Apart from these findings described above, miR-126 was found in neurons (Kim et al., 2014a (Kim et al., , 2014b and could target other pathways such as IGF-1 signaling, which may promote neurite sprouting, synapse formation, and neuronal survival in the central nervous system (Ryu et al., 2011; Zhang et al., 2008) . Thus, more research should be focused on this area.
In conclusion, in this study, we found that miR-126 expression decreased after SCI, but that increasing the levels of miR-126 rescued more white matter, promoted angiogenesis, reduced inflammation, and improved function deficit, which was concurrent with downregulation of expression of SPRED1, PIK3R2, and VCAM1 target genes; however, more research needs to be performed to understand the exact mechanisms underlying the effect of miR-126 in SCI.
4.
Experimental procedures
Animals and overall design
A total of 152 Sprague Dawley (SD) male rats were used (weight, 180-220 g; Central South University, Hunan Province, China) and were age-and weight-matched between groups 
within an experiment. All animal procedures were approved by the Laboratory Animal Users Committee of Central South University. An overview of all experimental groups is presented in Table 1 . We first determined whether upregulating miR-126 with agomir-126 could decrease the extent of injury and optimal dose for protecting white matter at 7 d post-injury. A dose-response study for white matter rescue was performed at the same time. Next, we determined whether a 7-d treatment with agomir-126 would improve locomotor function over 4 weeks. Additional groups of rats were used to investigate the effects and mechanisms of miR-126 on vascular and inflammatory responses at 1, 3, and 7 d.
All surgeries, behavioral measurements, and quantification of histological results were performed by testers blinded to the treatments. Treatments were assigned in a randomized order and were prepared by someone other than the surgeon.
Surgery
Rats were anesthetized by intraperitoneal injection of 0.3 mg/g body weight chloral hydrate (Kermel, Tianjing, China), and their backs were shaved and cleaned. After a midline incision and laminectomy at vertebral level T9/T10, spinal cord contusions were induced using a modified Allen's weight drop apparatus (8 g weight at a vertical height of 40 mm, 8 g Â 40 mm). A partial laminectomy at T12/T13 was performed for the placement of an intrathecal catheter. miR-126 agomir and miR-126 agomir negative control (NC) were from RiboBio (Guangzhou, China). In brief, the agomir-126 (5 0 -UCG UAC CGU GAG UAA UAA UGC G-3 0 ) or agomir-126 negative control (5 0 -UCA CAA CCU CCU AGA AAG AGU AGA-3 0 ), which was dissolved in saline (0.9%), was continuously delivered (1 μL/h) into the intrathecal space using subcutaneously implanted osmotic mini-pumps (Alzet 1030D, CA, USA) connected to a subdural-implanted catheter, as previously described (Liebscher et al., 2005) . Each pump was primed overnight at 37 1C to ensure immediate delivery after implantation. After the implantation, muscles were sutured in layers, the skin incision was closed with 3-0 silk threads, and 5 mL of lactated Ringer's solution was administered intraperitoneally. All surgeries were performed in a warm environment to maintain body temperature. After the surgery, rats were placed on fresh dry cages and given free access to food and water. Penicillin G (40,000 u, i. m.) was administered daily for 3 d to prevent infection. Bladders were manually expressed twice daily until full voluntary or autonomic voiding was obtained.
To determine the effects of miR-126 on the number of peripheral leukocytes, 1 mL of blood was drawn from the heart just before perfusion-fixation in rats that had been treated with negative control or agomir-126 for 7 d. Blood counts were performed with an automated hematology analyzer (Beckman Coulter, USA).
Functional testing
Functional recovery after SCI was determined at 1, 3, 7, 14, 21, and 28 d post-injury by two independent and well-trained testers blinded to treatment, using open-field overground locomotor performance according to Basso, Beattie, and Bresnahan (BBB) scores (Basso et al., 1995) . The final score for each animal was obtained by averaging the values from both testers. Rats with perineal infections, wounds in the limbs, or tail and foot autophagia were excluded from the test.
Histological procedures
Rats were perfused transcardially with phosphate-buffered saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Subsequently, the spinal cords were carefully dissected out, and 10-mm segments containing the injury site were post-fixed for 24 h at 4 1C.
To detect myelin in white matter tracts, 1 of every 5 of the transverse sections at each rostro-caudal 1-mm level was stained with Luxol fast blue, as previously described (Han et al., 2010) . After fixation, spinal cords were embedded in paraffin, sectioned at 5-mm thickness, and then mounted onto charged microscope slides for further use. Slides were placed in xylene at room temperature for two 20-min periods, passed through graded ethanol solutions (twice each in 100% and 95% ethanol, once in 70% ethanol, and twice in double-distilled H 2 O), and stained with 0.1% Luxol fast blue in 0.5% glacial acetic acid and 95% ethyl alcohol overnight at 56 1C. Next, the slides were gently washed in 95% ethanol to rinse off excess stain and then briefly rinsed in doubledistilled water. The slides were differentiated in 0.05% lithium carbonate solution, differentiated in 70% ethanol, briefly rinsed in double-distilled water, dehydrated briefly through graded ethanol solutions, cleared through xylene, Rats were treated with saline, negative control or agomir-126 (n ¼8) for 7 days after spinal cord injury and 1 mL blood was drawn from the heart for blood cell analysis before perfusion-fixation. Low red blood cell counts are probably due to bleeding caused by surgery. Data are mean7SEM values.
b r a i n r e s e a r c h 1 6 0 8 ( 2 0 1 5 ) 1 9 1 -2 0 2 and coverslipped. The injury epicenter was determined for each rat on the basis of the rostro-caudal level that contained the least amount of spared myelin per transverse section, to align all the histological measurements for each rat. Adjacent sections were stained with hematoxylin-eosin (HE) staining. To label the perfused blood vessels, the jugular vein was exposed and injected with 500 mg/250 mL fluorescein isothiocyanate-conjugated Lycopersicon esculentum agglutinin lectin (LEA; Sigma, USA) at 30 min before euthanasia. After intravenous injection, LEA binds only to endothelial cells of perfused blood vessels (Mazzetti et al., 2004) , allowing for simultaneous detection of endothelial cell survival in perfused blood vessels. Ten consecutive 30-μm transverse sections per millimeter along the spinal cord axis were cut and mounted onto charged microscope slides for further detection.
To detect immunofluorescent staining of CD45 (leukocytes) and CD68 (activated microglia/macrophages), spinal cords were placed in 30% phosphate-buffered sucrose overnight at 4 1C after fixation. Twenty consecutive 10-mm transverse sections at each 1-mm rostro-caudal level along the spinal cord axis were cut on a cryostat and thaw-mounted onto charged microscope slides. The sections were stored in sequence at -20 1C for further use. Slides were warmed for 30 min on a slide warmer, a ring of wax was applied around the sections with a PAP pen (Zsbio, Beijing, China), and the slides were rinsed in 0.1 M Trisbuffered saline (TBS) for 15 min. After blocking non-specific staining with 10% donkey serum in TBS containing 0.3% Triton X-100 for 1 h at room temperature, sections were incubated overnight at 4 1C in TBS, containing 5% donkey serum, mouse anti-CD45 (1:100; catalog number 05-1410, Millipore, Temecula, CA, USA), and mouse anti-CD68 (1:100; catalog number MCA341GA, ABD Serotec, Kindlington, Oxford, UK). Purified rat immunoglobulin G (IgG) was used as a control at the same concentrations instead of the primary antibody. Next, the sections were incubated in TBS-Triton containing 5% donkey serum with secondary antibodies (1:400; Jackson, USA) for 1 h at room temperature. Subsequently, sections were stained with 4 0 ,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Sigma, D9542, USA) for 10 min at room temperature. Finally, the sections were cover-slipped with antifade Gel/Mount aqueous mounting media (Beyotime, Shanghai, China). Between steps, sections were washed 3 times for 10 min in TBS. For normalizing all histological measurements, four sham-operated rats received a laminectomy only and were analyzed 7 d later.
Real-time polymerase chain reaction
From 10-mm long spinal cord segments containing the injury epicenter, total RNA was extracted with TRIzol (Invitrogen, CA, USA) according to manufacturer's instructions. To analyze microRNA expression by quantitative real-time PCR (qRT-PCR), RNA was reverse-transcribed using microRNA-specific primers from RiboBio. Real-time PCR was performed on diluted samples with miR-U6 as an internal control. For quantification of mRNA expression, first-strand synthesis was performed using a PrimeScript RT reagent kit (TaKaRa, Tokyo, Japan). Primers were designed and supplied by Sangon Biotech (Shanghai, China). Gene expression changes were quantified using the delta-delta CT method. 
Western blot
Rats were euthanized with an overdose of chloral hydrate. After the animals (n¼4 per group) were sacrificed, 10-mm long segments of spinal cord encompassing the injury site were then harvested for Western blot analyses. Protein concentrations were determined using a bicinchoninic acid (BCA) protein assay kit (Beyotime, Shanghai, China). Each protein sample (30 μg) was loaded for the assay. Nonspecific bands were blocked in TBS-T (25 mM Tris (Sigma), 150 mM NaCl, 0.05% Tween 20, pH 7.5) containing 5% non-fat milk for 1 h at room temperature. The film signals were digitally scanned and then quantified using the Quantity One 4.6.2 software (Bio-Rad, USA). An antibody for GAPDH (1:35,000; Sigma, USA) was used as an internal control. Data have been provided in terms of the mean7SD of the percentage ratio of the control.
Statistics
All data were analyzed using the IBM SPSS 19.0 statistical software. Two-way repeated measures ANOVA with the posthoc Tukey test was used to analyze the differences in BBB scores among groups over time. Statistically significant differences between two groups were determined by a two-tailed ttest. One-way ANOVA followed by post-hoc Tukey analysis was performed to compare groups of three or more. In cases where data were not normally distributed, the Kruskal-Wallis test was used. A value of Pr0.05 was considered statistically significant. Values are presented as mean7SEM.
